Theriva Biologics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Theriva Biologics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Theriva Biologics, Inc. Current Ratio for the quarter ending September 30, 2024 was 328 %, a 30.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 328 -144 -30.6% Sep 30, 2024
Q2 2024 365 -110 -23.1% Jun 30, 2024
Q1 2024 398 -80.9 -16.9% Mar 31, 2024
Q4 2023 423 -74.6 -15% Dec 31, 2023
Q3 2023 473 -129 -21.4% Sep 30, 2023
Q2 2023 475 -378 -44.3% Jun 30, 2023
Q1 2023 479 -924 -65.9% Mar 31, 2023
Q4 2022 497 -2.22K -81.7% Dec 31, 2022
Q3 2022 601 -1.68K -73.6% Sep 30, 2022
Q2 2022 853 -803 -48.5% Jun 30, 2022
Q1 2022 1.4K +516 +58.2% Mar 31, 2022
Q4 2021 2.71K +2.43K +860% Dec 31, 2021
Q3 2021 2.28K +1.98K +669% Sep 30, 2021
Q2 2021 1.66K +1.33K +406% Jun 30, 2021
Q1 2021 887 +486 +121% Mar 31, 2021
Q4 2020 283 -197 -41.1% Dec 31, 2020
Q3 2020 296 -324 -52.2% Sep 30, 2020
Q2 2020 328 -299 -47.7% Jun 30, 2020
Q1 2020 400 -99.2 -19.9% Mar 31, 2020
Q4 2019 480 +127 +36% Dec 31, 2019
Q3 2019 620 +415 +203% Sep 30, 2019
Q2 2019 627 +465 +286% Jun 30, 2019
Q1 2019 500 +350 +234% Mar 31, 2019
Q4 2018 353 +224 +175% Dec 31, 2018
Q3 2018 205 +90.5 +79.1% Sep 30, 2018
Q2 2018 162 +64.8 +66.5% Jun 30, 2018
Q1 2018 149 +54.8 +58% Mar 31, 2018
Q4 2017 128 +27.1 +26.8% Dec 31, 2017
Q3 2017 114 -7.62 -6.24% Sep 30, 2017
Q2 2017 97.4 -71.1 -42.2% Jun 30, 2017
Q1 2017 94.6 -45.6 -32.5% Mar 31, 2017
Q4 2016 101 -31.5 -23.7% Dec 31, 2016
Q3 2016 122 -5.74 -4.49% Sep 30, 2016
Q2 2016 169 +73.1 +76.5% Jun 30, 2016
Q1 2016 140 -31.5 -18.3% Mar 31, 2016
Q4 2015 133 -229 -63.3% Dec 31, 2015
Q3 2015 128 -933 -88% Sep 30, 2015
Q2 2015 95.5 Jun 30, 2015
Q1 2015 172 Mar 31, 2015
Q4 2014 361 Dec 31, 2014
Q3 2014 1.06K Sep 30, 2014
Q2 2013 3.09K +1.16K +59.7% Jun 30, 2013
Q1 2013 2.5K +390 +18.5% Mar 31, 2013
Q4 2012 1.87K Dec 31, 2012
Q3 2012 1.53K Sep 30, 2012
Q2 2012 1.93K Jun 30, 2012
Q1 2012 2.11K Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.